InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.42 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +125.50% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INM financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INM recently traded at $1.42. Market cap is $2.12M. P/E ratio is -0.08. Revenue is $4.94M.
| Metric | Value |
|---|---|
| Price | $1.42 |
| Market Cap | $2.12M |
| P/E Ratio | -0.08 |
| EPS | $-8.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.27 |
| 52-Week Low | $0.58 |
| Volume | 70.34M |
| Avg Volume | 0 |
| Revenue (TTM) | $4.94M |
| Net Income | $-8.16M |
| Gross Margin | 34.53% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.94M | $-8.16M | $-8.36 |
| 2024 | $4.60M | $-7.68M | $-1.01 |
| 2023 | $4.14M | $7.90M | $-3.25 |
| 2022 | $1.09M | $18.60M | $-33.17 |
INM analyst coverage data. Average price target: $0.00.